biomedical individuality and effective treatment strategies

53
ASI Conference – Oct 2008 Aurora, Illinois Anju I. Usman, M.D. True Health Medical Center Naperville, Illinois

Upload: dennis43

Post on 16-Dec-2014

3.036 views

Category:

Health & Medicine


8 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Biomedical Individuality and Effective Treatment Strategies

ASI Conference – Oct 2008Aurora, Illinois

Anju I. Usman, M.D.True Health Medical Center

Naperville, Illinois

Page 2: Biomedical Individuality and Effective Treatment Strategies
Page 3: Biomedical Individuality and Effective Treatment Strategies

Environmental ToxicityAnd Heavy Metal Burden

Genetics

Biologic and Immunological Triggers

Autism

Timing

Biomedical Causation Theories and

the Web of Interactions

Heavy Metal OverloadOxidative StressGut DysfunctionImmune DysregulationInflammation

Page 4: Biomedical Individuality and Effective Treatment Strategies

Genetic predispositionMother’s Burden

Toxic MetalsEnvironmental Pollutants

Electromagnetic FieldsSensory Input

Stress/Internal ConflictsDietary and Nutritional Factors

Microbial/BiofilmImmune/Inflammatory Burden

Page 5: Biomedical Individuality and Effective Treatment Strategies

Heavy Metal Overload Oxidative Stress Impaired Methylation Depletion of reduced

Glutathione

Mitochondrial Dysfunction

Gastrointestinal Dysfunction

Immune System Dysregulation

Microglial Activation The above lead to chronic

smoldering inflammation in the body and brain

Page 6: Biomedical Individuality and Effective Treatment Strategies

Heavy Metal Overload Elevated levels of Mercury, Lead, Aluminum… Mineral Deficiencies (Walsh, Adams) Abnormal Porphyrins (Nataf, Geiers)

Oxidative Stress (James,Salomon,Yorbik,Chauhan,Fuchs,Wagner,Pratico )

Impaired Methylation (James, Deth) Sulfation Abnormalities (Waring) Impaired Detoxification Depletion of antioxidants, vitamin cofactors Depletion of reduced Glutathione (James) Mitochondrial Insufficiency (Rossignol, Polling, …)

Gastrointestinal Dysfunction Immune System Dysregulation

Page 7: Biomedical Individuality and Effective Treatment Strategies

Oxidative Stress Antioxidant Defense

Superoxide DismutaseGSH Peroxidase

GSH ReductaseVitamin EVitamin C

Lipoic AcidGSTsGSH

Hydroxyl RadicalHydrogen Peroxide

SuperoxideONOO-GSSG4HNELOO-

Cell DeathDamage

Inflammation

Page 8: Biomedical Individuality and Effective Treatment Strategies

Maldigestion◦ Decreased activity of digestive enzymes (Horvath,1999. Buie, 2004)◦ High levels of opioid peptides found in urine of autistics. (Reichelt,

1997)◦ IgG Food Sensitivities

Malabsorption ◦ Fat Soluble Vitamin Deficiencies ◦ Essential Fatty Acid Deficiencies◦ Essential Amino Acid Deficiencies

Dysbiosis ◦ Dysbiosis or altered bowel flora (Rossenau, 2004)◦ Clostridial overgrowth (Sandler, 2002, MacFabe 2007)◦ Persistent measles virus (Wakefield, Krigsman)

Inflammation/Immune◦ Autistic Enterocolitis, Lymphoid Hyperplasia (Wakefield, Krigsman,

Balzola)◦ Increased intestinal permeability leading to food sensitivities and

autoimmunity (Vodjani, 2002)◦ Increased pro-inflammatory cytokines – LP, TNF alpha, IFN gamma (Ashwood, 2004)◦ Proinflammatory response to dietary proteins (Jyonuchi, 2004)

Page 9: Biomedical Individuality and Effective Treatment Strategies

Th1 and Th2 skewing◦ Abnormal cell-mediated immunity◦ Abnormal T-cell subsets, decreased NK cells, abnormal

cytokines, Th2 skewing (Zimmerman, 1998/Vodjani, 2008)◦ Decreased secretory IgA◦ Pro-inflammatory Factors in the Gut (Ashwood, Jyonuchi)

Pro-inflammatory Cytokines in the Brain◦ MCP-1, TGF beta-1 (Vargas,Pardo, 2005)◦ Abnormal EEG, Seizure activity◦ Microglial Activation and perivascular inflammation

Increased Autoimmunity◦ Autoantibodies to neural antigens (Connolly, 1999)◦ Myelin basic protein and Neuronal Axonal Filament Protein

Antibodies (Gupta, 1996 /Singh, 1997)

Page 10: Biomedical Individuality and Effective Treatment Strategies

History and Physical Examination Laboratory Testing Clean Up

◦ Environmental Controls◦ Dietary Interventions◦ Address Gastrointestinal Health

Foundational Nutrients Treat underlying Immune Issues and

Inflammation Support Detoxification/Mitochondrial

Pathways Heavy Metal/Chemical Detoxification

Page 11: Biomedical Individuality and Effective Treatment Strategies

Educational and Behavioral Therapies

Environmental ControlsEnvironmental Controls

Dietary Interventions Interventions

Nutrient TherapiesNutrient Therapies

Gastrointestinal Health

Immune Issues and InflammationImmune Issues and Inflammation

Promotion of Natural Detox and Mitochondria

Pharmaceutical Detox and other Drug therapy

Hyperbaric Oxygen TherapyHyperbaric Oxygen Therapy

Intensity of Symptoms = Intensity of Treatment

Page 12: Biomedical Individuality and Effective Treatment Strategies

•1122

Page 13: Biomedical Individuality and Effective Treatment Strategies

Casein/gluten peptides are broken down by DPPIV. This enzyme can be disabled by toxic metals and yeast.

High levels of opioid peptides (gliadorphin and caseomorphine) found in urine of autistics. (Reichelt, 1997)

Casein-free, Gluten-free diet may be an effective intervention (Whiteley,1999)

Presently NIH study underway

Page 14: Biomedical Individuality and Effective Treatment Strategies

Casein – protein from all dairy products◦ Caseomorphine= undigested casein peptide,

has an opiate effect on the brain Gluten – protein found in wheat, rye, oat,

barley, malt, spelt◦ Gliadorphin= partially digested gluten peptide,

has an opiate effect on the brain Urinary Peptides can be measured

Page 15: Biomedical Individuality and Effective Treatment Strategies

Jyonouchi H et al (2002) Neuropsychobiology 46 qq

Croonenberghs J et al (2002) Neuropsychobiology 45

Ashwood P et al (2004) J Clin Immuno 24: 664-673

Jyonouchi H et al (2005) Neuropsychobiology 51: 77-85

Page 16: Biomedical Individuality and Effective Treatment Strategies

It remains unclear how and when microglia and astroglia become activated in the brains of patients with autism. Glial responses in autism may be part of intrinsic, or primary, reactions that result from disturbances in glial function or neuronal-glial interactions during brain development. They may also be secondary, resulting from unknown disturbances (such as infections or toxins) in prenatal or postnatal CNS development. Nevertheless, the findings of this study highlight the existence of neuroimmunological processes in autism and provide a setting for new research approaches to the diagnosis and treatment of this debilitating neurological disorder.

Slides A and C, from patients with autism, show an increase in

neuron-supporting cells called glia. This increase is likely a sign of a neuroimmunological response to the disorder. © 2005 Pardo, Vargas

et al.

Page 17: Biomedical Individuality and Effective Treatment Strategies

The Neuroscientist, Volume 11, Number 5, 2005.Martha Herbert, MD, PhD ,

"neuroinflammation appears to be present in autistic brain tissue from childhood through adulthood." Dr. Herbert suggests that chronic disease or an external environmental source (like heavy metals) may be causing the inflammation. Excerpt: "Oxidative stress, brain inflammation, and microgliosis have been much documented in association with toxic exposures including various heavy metals...the awareness that the brain as well as medical conditions of children with autism may be conditioned by chronic biomedical abnormalities such as inflammation opens the possibility that meaningful biomedical interventions may be possible well past the window of maximal neuroplasticity in early childhood because the basis for assuming that all deficits can be attributed to fixed early developmental alterations in neural architecture has now been undermined.

““The brains of children with neurological The brains of children with neurological disorders are experiencing severe oxidative disorders are experiencing severe oxidative stress and inflammation, suggesting an stress and inflammation, suggesting an environmental cause. environmental cause.

Page 18: Biomedical Individuality and Effective Treatment Strategies

Glutamates◦ Monosodium

Glutamate (MSG)◦ Hydrolyzed Protein◦ Modified Food Starch◦ Natural Flavors◦ Peas, Mushrooms,

Tomatoes◦ Parmesan Cheese◦ Protein

Anti- Glutamates◦ Pycnogenol◦ Rosemary, Lemon Balm◦ Skull Cap, Chamomile◦ Taurine◦ GABA◦ L- Theanine◦ Vitamin K◦ Namenda (drug)◦ Minocycline (antibiotic) Excitotoxins = Substances that cause an excess of

excitatory neurotransmission in the brain. If inhibitory neurotransmission is lacking, chronic inflammation in the brain may result.

Page 19: Biomedical Individuality and Effective Treatment Strategies

2007 study in The Lancet examined the effect of artificial coloring and preservatives on hyperactive behavior in children. After consuming an additive-free diet for six weeks, the children were given either a placebo beverage or one containing a mix of additives in two-week intervals. In the additive group, hyperactive behaviors increased.

The study caused many pediatricians to rethink their skepticism about a link between diet and A.D.H.D. “The overall findings of the study are clear and require that even we skeptics, who have long doubted parental claims of the effects of various foods on the behavior of their children, admit we might have been wrong,” reported a February issue of AAP Grand Rounds, a publication of the American Academy of Pediatrics.

Page 20: Biomedical Individuality and Effective Treatment Strategies

Inadequate antioxidant status is a major pathway for inflammation. 

Various free rdicals (ROS), including superoxide, peroxide, hydroxyl and peroxynitrite, are generated through the inflammatory prostaglandin/leukotriene pathways.

These free radicals can damage or destroy virtually every cellular biomolecule: proteins, fatty acids, phospholipids, glycoproteins, even DNA, leading to cell injury or death. 

vitamins C and E are the two most important nutritional antioxidants.

Vitamin C, E, alpha-lipoic acid, Co Q10 and NADH act as a team.

One of the many ways excitotoxins damage neurons is to prevent the intracellular formation of glutathione.  

Page 21: Biomedical Individuality and Effective Treatment Strategies
Page 22: Biomedical Individuality and Effective Treatment Strategies

Rosemary Waring found low Sulfate levels in ASD. Low Sulfation leads to poor detoxification of Phenols.

PST Enzyme helps to detox Phenolic Substances from the body

Common Phenolic Substances ◦ Hormones◦ Salicylates (grapes, apples, strawberries)◦ Neurotransmitters◦ Biologic Agents (yeast)◦ Pesticides, Herbicides, Perfumes

Lack of sulfation may manifest as hyperactivity, stimming, lax ligaments, red cheeks and red ears.

Pyridoxal 5-Phosphate is a co-factor Epsom Salts/Magnesium Sulfate Baths may help

Page 23: Biomedical Individuality and Effective Treatment Strategies

Casein-free/Gluten-free/Diet Trial for 3-6 months. Avoid sugar and refined starch, replace with whole

grains Maximize antioxidants and phytonutrients. Limit processed and preserved foods; organic is best. Avoid excitotoxins (ex. Caffeine, MSG, NutraSweet, red/yellow food

dyes, nitrites, sulfites, glutamates, propionates, benzoates). Limit intake of phenolics (apples, grapes, strawberries…). Drink plenty of filtered water. Never microwave in plastics or Styrofoam, do not store

food in plastic or foil, or cook on Teflon coated pans. Eliminate seafood. Add good fats (olive, coconut, flax). Avoid hydrogenated and

trans fats and esterified fats. Buy hormone-free, antibiotic-free, organic meat and

eggs. Add fermented foods (coconut kefir, kombucha,…).

Page 24: Biomedical Individuality and Effective Treatment Strategies

CF/GF DietCF/GF Diet

Persistent Gut IssuesPersistent Gut Issues Hyperactivity/StimmingHyperactivity/Stimming

SpecificSpecificCarbohydrateCarbohydrate

DietDiet

Body Ecology Body Ecology DietDiet

Low Oxalate Low Oxalate Diet Diet

Avoid ExcitotoxinsAvoid Excitotoxins

Low Phenolic/FeingoldLow Phenolic/FeingoldDiet Diet

Low Copper DietLow Copper Diet

Elimination/RotationElimination/RotationDietDiet

Elimination/RotationElimination/RotationDietDiet

Dietary DetoursDietary Detours

Page 25: Biomedical Individuality and Effective Treatment Strategies

•Ames BN (2002) Ames BN (2002) High dose vitamin therapy stimulates High dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding variant enzymes with decreased coenzyme binding affinity (increased Km) : relevance to genetic disease affinity (increased Km) : relevance to genetic disease and polymorphisms.and polymorphisms. Am J Clin Nutr 75: 616-658 Am J Clin Nutr 75: 616-658

•Vieth R (2001) Vieth R (2001) Vitamin D nutrition and its potential Vitamin D nutrition and its potential health benefits for bone, cancer and other conditions.health benefits for bone, cancer and other conditions. J J Nutr & environmental med 11: 275-291. Nutr & environmental med 11: 275-291.

• Fernstom JD ( 2000) Fernstom JD ( 2000) Can Nutritional Supplements Can Nutritional Supplements modify brain function?modify brain function? Am J Clin nutr 71: 1669S-1673S. Am J Clin nutr 71: 1669S-1673S.

• Ames BN (2004) Ames BN (2004) A role for supplements in optimizing A role for supplements in optimizing health : the metabolic tune-up.health : the metabolic tune-up. Arch Biochem Biophys Arch Biochem Biophys 421: 227-234 421: 227-234

Page 26: Biomedical Individuality and Effective Treatment Strategies

•2266

Page 27: Biomedical Individuality and Effective Treatment Strategies

Dr. Bernie Rimland – Autism Research Institute

http://www.autismwebsite.com/ARI/treatment/b6studies.htm Studies of High Dosage Vitamin B6 (and

often with Magnesium) in Autistic Children and Adults, 1965 - 2005

Twenty-one of twenty-two studies yielded positive results, including 13 double-blind placebo-controlled trials; even minor adverse effects rarely were seen.

http://www.autismwebsite.com/ARI/dan/scientificfoundations.htmCompilation of Studies Supporting the Biomedical

Approach

Scientific Foundations of a Biomedical Approach to ASD

Page 28: Biomedical Individuality and Effective Treatment Strategies

Pyridoxal 5-phosphate (P5P) active form of vitamin B6

Conversion of B6 to P5P requires: ATP, Mg, Zn, Vit B2

Used by 112 enzymes Transamination reactions Decarboxylation ( L-Dopa to Dopamine,

5HTP to Serotonin, Glutamic Acid to GABA) Tryptophan metabolism

◦ breakdown of hydroxykynurenin◦ niacin production

Glycogenolysis (breakdown of glycogen)

•2288

Page 29: Biomedical Individuality and Effective Treatment Strategies

Symptoms◦ Morning nausea◦ Frequent mood swings◦ Difficult handling transitions◦ Poor short term memory◦ Poor stress handling

Avoidance Seclusion Over reaction, meltdowns Overly dramatic

◦ Sensory issues (light, sound, touch, taste, smell)

◦ Burn easy in sun, do not tan◦ Poor dream recall◦ Vivid dreams, nightmares◦ Nervousness, Panic, Anxiety◦ Irish ancestry◦ Seizure disorder

Physical Exam◦ Glossitis, mouth ulcers◦ Dry skin, cracked lips

and nails◦ Spleen tenderness◦ China doll skin◦ Spider veins◦ Sweet breath◦ Crowded upper front

teeth◦ Red hair, blue eyes◦ Peripheral neuropathy

Laboratory Findings◦ Urinary Kryptopyrrole

Level Above 10 mcg/dl

Page 30: Biomedical Individuality and Effective Treatment Strategies

•.5.5

•1.01.0

•1.51.5

•2.02.0

•1010 •2525 •5050 •7575 •9090

•PercentilePercentile

• Cu

/Zn

C

u/Z

n

Rati

oR

ati

o •AutisticsAutistics

•ControlsControls

503 Patients with ASD503 Patients with ASD• Mean Cu/Zn ratio 1.63 in ASDMean Cu/Zn ratio 1.63 in ASD• Mean Cu/Zn ratio 1.15 in ControlsMean Cu/Zn ratio 1.15 in Controls

Pfeiffer Treatment Center Data Pfeiffer Treatment Center Data 20012001

Page 31: Biomedical Individuality and Effective Treatment Strategies

Neurotransmitter imbalances (high platelet serotonin, low dopamine, high norepinephrine)

Abnormal EEG and seizure activity Hyperactivity Poor attention span Explosive Temper Poor Short Term Memory Speech Delay Yeast Overgrowth

Page 32: Biomedical Individuality and Effective Treatment Strategies

Treat Zinc deficiency until Zinc level optimized (100mcg/dl)

Induce Metallothionein (MT) production using Selenium and Glutathione

Add Manganese and Molybdenum in small doses Provide adequate amounts of vitamin

B6/Magnesium Optimize Vitamin C dose Avoid Sources of Copper

• Tap water (Cu pipes)• Swimming pools and hot tubs (Cu algaecide)• Chocolate, Carob, Soy, Shellfish, Liver

Avoid Red/ Yellow dyes and MSG (deplete Zn) Consider Carnosine supplementation

Page 33: Biomedical Individuality and Effective Treatment Strategies

◦ Improves methylation, glutathione, oxidative stress.

◦ Jill James Study.◦ Methylation also helps with the production and

metabolism of Dopamine, Serotonin, Norepinephrine and Epinephrine.

◦ Shown to help cognitive ability, abstract thinking, attention, focus, awareness, language, behavior, OCD, anxiety, ….(Neubrander, 2004).

◦ No test for methylB12 deficiency.◦ Consider 3 month trial.◦ Side effects – increased energy, hyperactivity,

agitation, stimming.◦ Protocol 75 mcg/kg subcutaneous injection every 3rd day◦ Parents give the preservative-free, methyl B12 injections themselves.

Page 34: Biomedical Individuality and Effective Treatment Strategies

Essential fatty acids, DHA and human brain development Indian J.Pediatr Mar 2005◦ Infants of mothers supplemented with EFAs and DHA had

higher mental processing, psychomotor scores, and eye-hand coordination. EFAs may prevent ADHD in preschoolers.

Long chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders Lipids Dec 2004 ◦ LC-PUFA help with childhood behavior and learning difficulties.

Omega-3 Fatty Acids Supplementation in Children with Autism: A Double-blind Randomized, Placebo-controlled Pilot Study◦ EFA helped with hyperactivity and sterotypy in ASD children.

Page 35: Biomedical Individuality and Effective Treatment Strategies

Essential Fats are fats that your body can not manufacture. They need to be consumed.

These fats are essential for neuronal transmission, cell to cell communication, normalizing excitation, maintaining skin, hair, joint structure, and minimizing inflammation.

Omega 3 ◦ Fish, Flax, Seaweed

Omega 6◦ Safflower, Sunflower, Corn, Borage, Evening Primrose

Omega 9◦ Olive, Avocado, Coconut

Page 36: Biomedical Individuality and Effective Treatment Strategies

Minerals◦ Zinc 2-3mg/kg◦ Magnesium 10-30mg/kg◦ Selenium 100-200mcg◦ Molybdenum 100-250mcg◦ Calcium 200-1000mg per day

Vitamins◦ B6 100-500mg/day◦ Methyl B12 injections

Antioxidants◦ Vitamin C 500-1500mg/day◦ Vitamin E 200-800 IU/day◦ Vitamin A 2500-15,000iu/day◦ Vitamin D 2000 IU/day◦ Glutathione 200mg per day◦ Melatonin 1-3 mg/day

EFA◦ Omega 3 EFA 1000mg

Page 37: Biomedical Individuality and Effective Treatment Strategies

Daily bowel movements are a goal. Add digestive enzymes with meals. Start high potency probiotics (acidophilus

and bifidus) or probiotic containing foods. Start treatment for dysbiosis depending on

symptoms and labs. Check for high ammonia, treat accordingly.

If persistent symptoms:◦ Eliminate disaccharides from diet for 3-6 months

Specific Carbohydrate Diet (SCD)

◦ Consider referral to knowledgeable GI specialist◦ Consider trial of IV or nasal Secretin. ◦ Treat with natural anti-inflammatories.

Page 38: Biomedical Individuality and Effective Treatment Strategies

CBC Comprehensive Metabolic Panel Serum Copper Plasma Zinc Ceruloplasmin Hair Analysis Thyroid profile Blood Lead Ammonia

Intracellular Minerals and Metals Urine Essential Minerals Essential Fatty Acids Amino Acids Plasma cysteine, sulfate, rGSH

Urine Organic Acids Test (OATS) Stool Microbiology Stool Mycology Stool Parasitology

Immune Markers◦ Immunoglobulin Levels◦ T lymphocyte Panel◦ Natural Killer Cell Activity◦ PANDA’s Profile◦ Anti MBP Ab◦ Anti NAFP Ab◦ IgG Food Ab Panel◦ Vaccine Titers◦ Viral Titers

Urinary Peptides Hormone Studies Neurotransmitter Levels Genomics – SNPs

Urine/ Fecal Toxic Metals Urinary Porphryins Urinary Neopterin Urinary 8-OH Guanosine Organophosphate Levels

Page 39: Biomedical Individuality and Effective Treatment Strategies

These agents create inflammation, free radicals and oxidative stress.

Some of these biologic agents produce neurotoxins and excitotoxins and other toxic by-products.

Some agents increase cell membrane permeability.

Our body may produce antibodies to these agents. These antibodies may cross react with our own tissue creating an autoimmune reaction. This is called molecular mimicry.

Page 40: Biomedical Individuality and Effective Treatment Strategies

Clostridia produce Clostridia produce toxins (propionic toxins (propionic acid)acid)and enzymes that and enzymes that create severe gutcreate severe gutinflammation, inflammation, produceproducewatery diarrhea, watery diarrhea, and can cause and can cause behavior changes. behavior changes.

Page 41: Biomedical Individuality and Effective Treatment Strategies

American Journal of Biochemistry and Biotechnology 4 (2): 146-166, 2008

Derrick F. MacFabe

Innate neuroinflammatory changes, increased oxidative stress and disorders of glutathione metabolism may be involved in the pathophysiology of autism spectrum disorders (ASD). Propionic acid (PPA) is a dietary and gut bacterial short chain fatty acid which can produce brain and behavioral changes reminiscent of ASD following intraventricular infusion in rats treatment day, specific brain regions were assessed for neuroinflammatory or oxidative stress markers. ..

Immunohistochemical analyses revealed reactive astrogliosis (GFAP), activated microglia (CD68,Iba1) without apoptotic cell loss (Caspase 3’ and NeuN) in hippocampus and white matter (external capsule) of PPA treated rats. Biomarkers of protein and lipid peroxidation, total glutathione (GSH) as well as the activity of the antioxidant enzymes superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione S-transferase (GST) were examined in brain homogenates. Some brain regions of PPA treated animals (neocortex, hippocampus, thalamus, striatum) showed increased lipid and protein oxidation accompanied by decreased total GSH in neocortex. Catalase activity was decreased in most brain regions of PPA treated animals suggestive of reduced antioxidant enzymatic activity. GPx and GR activity was relatively unaffected by PPA treatment while GST was increased, perhaps indicating involvement of GSH in the removal of PPA or related catabolites. Impairments in GSH and catalase levels may render CNS cells more susceptible to oxidative stress from a variety of toxic insults. Overall, these findings are consistent with those found in ASD patients and further support intraventricular PPA administration as an animal model of ASD.

Page 42: Biomedical Individuality and Effective Treatment Strategies

Symptoms◦ Aggressive◦ Temper◦ Agitation◦ Irritable◦ Very foul stools◦ Mucus in stools◦ Severe diarrhea

following antibiotic use

Treatment ◦ Probiotics, High Potency

single strain◦ Sacchyromyces

Boulardii◦ Antibiotics

Vancomycin Metronidazole (Flagyl)

◦ Immune modulators◦ Homeopathics◦ HBOT

Page 43: Biomedical Individuality and Effective Treatment Strategies

Symptoms ◦ Spacey◦ Foggy thinking◦ Inappropriate

laughter◦ Sugar cravings◦ Poor sleep◦ Frequent diaper

rash◦ Frequent urination◦ History of frequent

antibiotics

Treatment Options◦ Limit carbs, sugar,

yeast◦ Probiotics◦ Sacchromyces

Boulardii◦ Zinc, Molybdenum◦ Antifungals

Drugs Nystatin, Amphotericin B Fluconazole Itraconazole Ketoconazole

Herbals Berberine Grapefruit Seed Extract Oil of Oregano, Pau d’Arco Garlic, Samento, …

◦ Enzymes◦ Homeopathics

Page 44: Biomedical Individuality and Effective Treatment Strategies

Symptoms◦ Bizarre Behavior◦ Insatiable Appetite◦ Aggressive◦ Worse at full moon◦ Picking, biting, licking,

itching, grinding◦ Fecal smearing◦ Restlessness

Treatment ◦ Probiotics◦ Antiparasitic Drugs

Flagyl Paromomycin Mebendazole

◦ Natural Remedies Wormwood(artemesia) Black Walnut Pumpkin Seeds Clove Coconut Oil

◦ Homeopathics Combo remedies Cina

Page 45: Biomedical Individuality and Effective Treatment Strategies

J Neurosci Res. 2007 Apr;85(5):1143-8.

Evidence for Mycoplasma ssp., Chlamydia pneunomiae, and human herpes virus-6 coinfections in the blood of patients with autistic spectrum disorders.

Nicolson GL, Gan R, Nicolson NL, Haier J.

We examined the blood of 48 patients from central and southern California diagnosed with autistic spectrum disorders (ASD) by using forensic polymerase chain reaction and found that a large subset (28/48 or 58.3%) of patients showed evidence of Mycoplasma spp. infections compared with two of 45 (4.7%) age-matched control subjects (odds ratio = 13.8, P < 0.001). Because ASD patients have a high prevalence of one or more Mycoplasma spp. and sometimes show evidence of infections with Chlamydia pneumoniae, we examined ASD patients for other infections. Also, the presence of one or more systemic infections may predispose ASD patients to other infections, so we examined the prevalence of C. pneumoniae (4/48 or 8.3% positive, odds ratio = 5.6, P < 0.01) and human herpes virus-6 (HHV-6, 14/48 or 29.2%, odds ratio = 4.5, P < 0.01) coinfections in ASD patients. We found that Mycoplasma-positive and -negative ASD patients had similar percentages of C. pneumoniae and HHV-6 infections, suggesting that such infections occur independently in ASD patients. Control subjects also had low rates of C. pneumoniae (1/48 or 2.1%) and HHV-6 (4/48 or 8.3%) infections, and there were no coinfections in control subjects. The results indicate that a large subset of ASD patients shows evidence of bacterial and/or viral infections (odds ratio = 16.5, P < 0.001). The significance of these infections in ASD is discussed in terms of appropriate treatment. (c) 2007 Wiley-Liss, Inc. PMID: 17265454 [PubMed - indexed for MEDLINE]

Page 46: Biomedical Individuality and Effective Treatment Strategies

Medical Hypothesis

The Association between Tick-Borne Infections, Lyme Borreliosis and Autism Spectrum Disorders

Robert C Bransfield, MD

      A Lyme Induced Autism Foundation conference was held in June 2007 in Irvine, California to explore the association between infectious diseases, tick-borne infections, including Lyme Borreliosis (Borrelia burgdorferi) and autism spectrum disorders. There are multiple cases of mothers with Lyme disease and children with autism spectrum disorders; significant fetal neurological abnormalities associated with tick-borne diseases; improvement in autistic symptoms in some autism spectrum disorder patients from antibiotic treatment; similarities between the clinical manifestations of tick-borne diseases and autism spectrum disorder regarding pathophysiology, treatment responses, immune reactivity, temporal lobe pathology, and brain imaging data.

      Pilot studies of autism spectrum disorder patients demonstrate positive reactivity for Borrelia burgdorferi at 22% (Vojdani) and 26% (Lyme Induced Autism Foundation) and 58% for Mycoplasma (including M. fermentans and M. pneumoniae), 8% for Chlamydia pneumoniae and 29% for Human Herpes Virus-6 (Nicolson). In addition, geographical patterns of a greater incidence of autism spectrum disorders approximate regions that are more endemic for tick-borne diseases.

      It is hypothesized that chronic infectious diseases, including tick-borne infections such as Borrelia burgdorferi may have direct effects, promote other infections and create a weakened, sensitized and immunologically vulnerable state during fetal development and infancy leading to increased vulnerability for developing autism spectrum disorders.

Page 47: Biomedical Individuality and Effective Treatment Strategies

Symptoms◦ Ritualistic◦ Repetitive◦ Verbal tics◦ Obsessive◦ Compulsive◦ Verbal stims◦ Frequent strep

infections◦ Frequent bacterial

infections

Treatment Options◦ Probiotics◦ Alkalinization◦ Xylitol◦ Antibacterial Herbs

Goldenseal, Berberine Artemesia Neem

◦ Immune modulators Oral Immunoglobulins Transfer Factors Colostrum Mushroom Extracts Glycans Plant Sterols

◦ Drugs Penicillin Zithromax

Page 48: Biomedical Individuality and Effective Treatment Strategies

DADA

Page 49: Biomedical Individuality and Effective Treatment Strategies

Gillberg IC.

Autistic syndrome with onset at age 31 years: herpes encephalitis as a possible model for childhood autism.

Dev Med Child Neurol. 1991 Oct;33(10):920-4. PMID: 1743418 [PubMed - indexed for MEDLINE]

DeLong GR, Bean SC, Brown FR 3rd.

Acquired reversible autistic syndrome in acute encephalopathic illness in children.

Arch Neurol. 1981 Mar;38(3):191-4. PMID: 6162440 [PubMed - indexed for MEDLINE]

Caruso JM, Tung GA, Gascon GG, Rogg J, Davis L, Brown WD.

Persistent preceding focal neurologic deficits in children with chronic Epstein-Barr virus encephalitis.

J Child Neurol. 2000 Dec;15(12):791-6. PMID: 11198493

Sweeten TL, Posey DJ, McDougle CJ.

Brief report: autistic disorder in three children with cytomegalovirus infection.

J Autism Dev Disord. 2004 Oct;34(5):583-6. PMID: 15628611

Page 50: Biomedical Individuality and Effective Treatment Strategies

Symptoms ◦ Easy Fatigue◦ Visual Issues

Squinting Divergent Gaze Poor Eye Contact

◦ Cold sores◦ Warts◦ History of Regression

after MMR or other live viruses

Treatment Options◦Antiviral Agents

Olive Leaf Extract, Elderberry

Caprylic Acid High Dose Vitamin A

◦Antiviral Drugs Acyclovir Valacyclovir Famvir Imunovir

◦Immune Support Low Dose Naltrexone Red. Glutathione Zinc Immune Modulators

Page 51: Biomedical Individuality and Effective Treatment Strategies

Mol Pathol. 2002 Apr;55(2):84-90.

Potential viral pathogenic mechanism for new variant inflammatory bowel disease.

Uhlmann V, Martin CM, Sheils O, Pilkington L, Silva I, Killalea A, Murch SB, Walker-Smith J, Thomson M, Wakefield AJ, O'Leary JJ.

A new form of inflammatory bowel disease (ileocolonic lymphonodular hyperplasia) has been described in a cohort of children with developmental disorder. This study investigates the presence of persistent measles virus in the intestinal tissue of these patients (new variant inflammatory bowel disease) and a series of controls by molecular analysis. METHODS: Formalin fixed, paraffin wax embedded and fresh frozen biopsies from the terminal ileum were examined from affected children and histological normal controls. The measles virus Fusion (F) and Haemagglutinin (H) genes were detected by TaqMan reverse transcription polymerase chain reaction (RT-PCR) and the Nucleocapsid (N) gene by RT in situ PCR. Localisation of the mRNA signal was performed using a specific follicular dendritic cell antibody. RESULTS: Seventy five of 91 patients with a histologically confirmed diagnosis of ileal lymphonodular hyperplasia and enterocolitis were positive for measles virus in their intestinal tissue compared with five of 70 control patients. Measles virus was identified within the follicular dendritic cells and some lymphocytes in foci of reactive follicular hyperplasia. The copy number of measles virus ranged from one to 300,00 copies/ng total RNA. CONCLUSIONS: The data confirm an association between the presence of measles virus and gut pathology in children with developmental disorder.

Page 52: Biomedical Individuality and Effective Treatment Strategies

Healing the New Childhood Epidemics (Autism, ADHD, Asthma and Allergies, Ken Bock MD

Autism: Effective Biomedical Treatments, Pangborn and Baker

Children with Starving Brains, Jaquelyn McCandless MD Special Diets for Special Kids, Lisa Lewis Evidence of Harm, David Kirby Excitotoxins, the Taste that Kills, Russel Blaylock MD Websites

www.autismresearchinstitute.org (www.autism.com) www.safeminds.org www.autismone.org www.generationrescue.org www.vaccineawareness.com www.ddr.org www.gfcfdiet.com

Page 53: Biomedical Individuality and Effective Treatment Strategies

PHONE: (630) 995-4242

FAX: (630) 995-4243